Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Houghten Pharm

Article Abstract:

Two executives of Houghten Pharmaceuticals recently purchased 60,000 company shares at $4.25 to $6.34 each. Former Chief Scientific Officer Ronald Tuttle bought 30,000 shares, bringing his common holdings to 18%, while Director and Beneficial Owner James Blair also acquired 30,000 shares. These insider buying activities seem to signal that Houghten stock is gaining momentum and rising beyond its basing pattern. Houghten Pharmaceuticals develops drug therapies.

Publisher: Thomson Financial Inc.
Publication Name: CDA-Investnet Insiders' Chronicle
Subject: Business
ISSN: 1074-0139
Year: 1997
Pharmaceutical Preparation Manufacturing, Pharmaceutical Preparations, Drugs, Houghten Pharmaceuticals Inc., HPIP

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


SPI Pharmaceuticals Inc

Article Abstract:

Six officers of SPI Pharmaceuticals Inc. have sold a total of 213,397 shares of their corporation's stocks at prices ranging from $15.50 to $20.50 per share from Jan to Feb 1993. The extremely high insider stock disposition has been considered as a negative indicator of the feasibility of the firm in the near future. The company has a total of 17.6 million shares and manufactures over 600 prescription and non-prescription products.

Publisher: Thomson Financial Inc.
Publication Name: CDA-Investnet Insiders' Chronicle
Subject: Business
ISSN: 1074-0139
Year: 1993
Evaluation, Insider trading in securities, Insider trading (Securities), SPI Pharmaceuticals Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Belmac Corp

Article Abstract:

Belmac Corp is a researcher, developer and distributor of pharmaceuticals. The stock has declined from $13.50 to the $2 area since Aug 1992, and yet insider sales were noted at low prices. Three insiders got out of 75,281 shares from Feb 28 to Mar 30, 1993, as the price dropped from $4 to $2.94. Outsider sales have also escalated so a guarded outlook is recommended.

Publisher: Thomson Financial Inc.
Publication Name: CDA-Investnet Insiders' Chronicle
Subject: Business
ISSN: 1074-0139
Year: 1993
Commercial physical research, Belmac Corp.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Pharmaceutical industry, Securities
Similar abstracts:
  • Abstracts: Echlin Inc. Regal-Beloit Corp. Superior Industries International
  • Abstracts: Kansas City Southern - KSU. Santa Fe Pacific Corp. Consolidated Rail Corp
  • Abstracts: Buy side commentary. Buy side activity. How much has the foundation weakened?
  • Abstracts: Caremark International Inc. Health Care & Retirement Corp
  • Abstracts: Value Health Inc. Medco Containment Services Inc
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.